Sign In
26 Nov 2013 10:46
For immediate release | 26 November 2013 |
ABCAM PLC
("Abcam" or "the Company")
Director/PDMR dealing: LTIP
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of innovative protein research tools to help life scientists discover more, announces that on 25 November 2013 the Remuneration Committee granted the following nil cost share awards based on a price of 464 pence per 0.2 pence Ordinary Share (the closing share price on 22 November 2013) to the Executive Directors and PDMRs of the Company under the Abcam plc Long-Term Incentive Plan (the "LTIP"):
Name | Number of 0.2 pence Ordinary Shares subject to the LTIP Award
| |
Executive Directors: | Jonathan Milner | 38,035 |
Jim Warwick | 27,259 | |
Jeff Iliffe | 27,259 | |
PDMRs: | Mark Bushfield | 13,833 |
Jane Cooke | 6,528 | |
Philippe Cotrel | 13,833 | |
Alan Hirzel | 25,104 | |
Danielle Miller | 5,061 | |
Ed Ralph | 9,346 | |
The shares subject to the LTIP Award will be released in three years time subject to continued employment and subject to a performance condition based on growth in earnings per share.
For further information please contact:
Abcam | + 44 (0) 1223 696 000 |
Jeff Iliffe, Chief Financial Officer
| |
Numis Securities - Nominated Adviser & Joint Broker | + 44 (0) 20 7260 1000 |
Michael Meade - Nominated Adviser | |
James Black - Corporate Broking
| |
Peel Hunt LLP - Joint Broker | + 44 (0) 20 7418 8900 |
Andy Crossley - Corporate Broking
| |
Buchanan | + 44 (0) 20 7466 5000 |
Mark Court / Fiona Henson / Sophie Cowles |
Notes for editors:
About Abcam plc
Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level to improve the understanding of health and disease.
Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 127,000 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported with detailed, up-to-date and unbiased data on our website.
Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices and ships to over 100 countries. The Company was founded in 1998, and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).
To find out more, please visit www.abcam.com
Follow the stocks
